Literature DB >> 23590876

Blood/plasma secretome and microvesicles.

Jameel M Inal1, Uchini Kosgodage, Sarah Azam, Dan Stratton, Samuel Antwi-Baffour, Sigrun Lange.   

Abstract

A major but hitherto overseen component of the blood/plasma secretome is that of extracellular vesicles (EVs) which are shed from all blood cell types. These EVs are made up of microvesicles (MVs) and exosomes. MVs, 100nm-1μm in diameter, are released from the cell surface, and are a rich source of non-conventionally secreted proteins lacking a conventional signal peptide, and thus not secreted by the classical secretory pathways. Exosomes are smaller vesicles (≤100nm) having an endocytic origin and released upon multivesicular body fusion with the plasma membrane. Both vesicle types play major roles in intercellular cross talk and constitute an important component of the secretome especially in the area of biomarkers for cancer. The release of EVs, which are found in all the bodily fluids, is enhanced in cancer and a major focus of cancer proteomics is therefore targeted at EVs. The blood/plasma secretome is also a source of EVs, potentially diagnostic of infectious disease, whether from EVs released from infected cells or from the pathogens themselves. Despite the great excitement in this field, as is stated here and in other parts of this Special issue entitled: An Updated Secretome, much of the EV research, whether proteomic or functional in nature, urgently needs standardisation both in terms of nomenclature and isolation protocols. This article is part of a Special Issue entitled: An Updated Secretome.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood/plasma; Exosome; Microvesicle; Secretome

Mesh:

Substances:

Year:  2013        PMID: 23590876     DOI: 10.1016/j.bbapap.2013.04.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

Review 1.  Extracellular membrane vesicles in the three domains of life and beyond.

Authors:  Sukhvinder Gill; Ryan Catchpole; Patrick Forterre
Journal:  FEMS Microbiol Rev       Date:  2019-05-01       Impact factor: 16.408

2.  Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue.

Authors:  Gunisha Sagar; Raghuwansh P Sah; Naureen Javeed; Shamit K Dutta; Thomas C Smyrk; Julie S Lau; Nino Giorgadze; Tamar Tchkonia; James L Kirkland; Suresh T Chari; Debabrata Mukhopadhyay
Journal:  Gut       Date:  2015-04-28       Impact factor: 23.059

Review 3.  Extracellular vesicles in diagnosis and therapy of kidney diseases.

Authors:  Wei Zhang; Xiangjun Zhou; Hao Zhang; Qisheng Yao; Yutao Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

4.  Localized Cell-Surface Sampling of a Secreted Factor Using Cell-Targeting Beads.

Authors:  Tammi L van Neel; Samuel B Berry; Erwin Berthier; Ashleigh B Theberge
Journal:  Anal Chem       Date:  2020-10-02       Impact factor: 6.986

5.  Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells.

Authors:  Jae Hun Jung; Min Young Lee; Do-Young Choi; Jae Won Lee; Sungyong You; Kye Young Lee; Jayoung Kim; Kwang Pyo Kim
Journal:  Proteomics       Date:  2015-01-16       Impact factor: 3.984

6.  Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

Authors:  Ayumu Taguchi; Oliver Delgado; Müge Celiktaş; Hiroyuki Katayama; Hong Wang; Adi F Gazdar; Samir M Hanash
Journal:  Proteomics       Date:  2014-11-20       Impact factor: 3.984

7.  Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.

Authors:  Marta Adamiak; Guangming Cheng; Sylwia Bobis-Wozowicz; Lin Zhao; Sylwia Kedracka-Krok; Anweshan Samanta; Elzbieta Karnas; Yu-Ting Xuan; Bozena Skupien-Rabian; Xing Chen; Urszula Jankowska; Magdy Girgis; Malgorzata Sekula; Arash Davani; Slawomir Lasota; Robert J Vincent; Michal Sarna; Kathy L Newell; Ou-Li Wang; Nathaniel Dudley; Zbigniew Madeja; Buddhadeb Dawn; Ewa K Zuba-Surma
Journal:  Circ Res       Date:  2017-11-08       Impact factor: 17.367

8.  Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis.

Authors:  Taixue An; Sihua Qin; Yong Xu; Yueting Tang; Yiyao Huang; Bo Situ; Jameel M Inal; Lei Zheng
Journal:  J Extracell Vesicles       Date:  2015-06-19

9.  A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study.

Authors:  Yixing Wu; Hongmei Zeng; Qing Yu; Huatian Huang; Beatrice Fervers; Zhe-Sheng Chen; Lingeng Lu
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

10.  Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence.

Authors:  Ombretta Repetto; Federica Lovisa; Caterina Elia; Daniel Enderle; Filippo Romanato; Salvatore Buffardi; Alessandra Sala; Marta Pillon; Agostino Steffan; Roberta Burnelli; Lara Mussolin; Maurizio Mascarin; Valli De Re
Journal:  Diagnostics (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.